RNA-virus caused diseases pose a challenging problem for a deep epidemiological comprehension due to the trick nature of the population genetics of such viruses and the sometimes obscure host-parasite relationship at the molecular level.
INTRODUCTION
The generation of biochemical diversity for an RNA virus is mainly a consequence of polymerase errors such as misincorporation of nucleotides leading to substitutions, insertions and deletions or, in a more severe way, recombination with another genome.
The outcome of the now new genotype will be subjected to selection by the immune system of the host, chiefly by antibodies and T lymphocytes and the binding of viral proteins to cell membrane receptors. Also, selection might be speculated as a result of the degree of affinity between cell ribosomes and viral messenger RNAs and the availability of host transporter RNAs (tRNAs) for each codon in viral genome as balanced by the codon-selection process (Jenkins & Holmes 2003 , Shackelton & Holmes 2008 ) and virus-cell protein-protein interactions in the cytoplasm.
Once selected, whether the new genotype will lead to a sustained transmission depends now on its virulence, on the host density and herd immunity and even on the host size, as it can be proposed that, for a same pathogen, a host with a larger infectable surface will present a higher probability of infection than one with a lower surface (Hall et al. 2007 ) and thus a higher frequency of infection is expected for this host species.
Despite the vast knowledge on the molecular biology of parasites and hosts and on the stochastic epidemiology of many infectious diseases, integrative frameworks for the connection of these systems are scarce.
The aim of this article is to expose in a qualitative mode the elements that connect virus genotypes and phenotypes to disease transmission and the host-parasite relationship in order to propose a theoretical framework for the evolution of infectious VIRUS REVIEWS AND RESEARCH 15, Nr. 2, 2010 55 diseases taking an RNA-virus caused disease as a model under an epidemic mode of occurrence.
Competitive molecular evolution in a pathogen species.
Let's consider a given phenotype of an infectious pathogen, for instance, an RNA-virus. The term phenotype in this case derives from protein characteristics of this pathogen, such as antigenic patterns, protection features or any other features based on the amino acids point of view of both structural and non-structural proteins that allow the pathogen to be noticed in a given environment in a way that differs from phenotype to phenotype restricted to the species compartment.
A more relaxed view of phenotype should include structural RNAs, which plays phenotypical roles in the activation of RNA replicases and genomic RNA encapsidation, which structural plasticity allows these molecules to regulate transitions between different biochemical paths (Simon and Gehrke 2009 ).
Thanks to the degeneracy of the genetic code, an amino acid or a group of amino acids that confer the phenotype determination can be coded by non-identical sets of nucleotides, resulting that a wide range of genomes population might exist inside the phenotype compartment and, at the evolutionary level, it means that the rate of nucleotide mutation has a given space of probabilities to occur which is limited by the phenotypical definition, what has already been proposed as neutral networks (Koelle et al. 2006) , according to which a set of genotypes results in the same phenotype.
Let PhI be the phenotype 1 of a hypothetical RNA virus, translatable as a given serotype, and the space of mutation probabilities for this phenotype restricted by genotypes 1 to M, making the neutral network I (for phenotype I) genotypically defined as GI 1,M , with a fitness of w I , being the fitness defined as a measure of population growth success and high mutation robustness (Biebricher & Eigen 2005 , Belshaw et al. 2008 ).
The primary biochemical source of nucleotide diversity between two genomes of a same species or, in this case, of a same neutral network, is the enzymatic replication components of the phenotype, what is of major relevance when a RNA virus is under consideration, taking into account that RNA polymerases are much more prone to misincorporation of nucleotides when compared to DNA polymerases, although a 3'-5' exoribonuclease has been described for some RNA viruses (Chen et al. 2007 ).
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56 Nucleic acids polymerases thus provide newly synthesized genomes with nucleotide substitutions, insertions and deletions and also with recombinations as, for instance, in the copy-choice phenomenon of RNA-dependent RNA-polymerases (Lai 1992 ), but all these mutations are still subjected to the limitations of the genetic code degeneracy-dependent definition of PhI.
In a self-sustained model for the emergence of nucleotide mutations for PhI, both the ancestor genomes and the newly synthesized mutants predicted for GI 1, M are now templates for the next generation of genomes if the pathogen is replicating, leading the system to the probability of the emergence of a new genotype for phenotype I that differs from GI 1 to GI M (GI ≠1,M ).
Nucleotide and also amino acids mutations with a low significance at the phenotypical level accumulate and the space of nucleotide mutations probability for PhI thus expands, leading to the inflation of neutral network I.
Specifically regarding the amino acids mutations, the chain of events that will follow after the emergence of such substitutions and the new mutant PhI subpopulation depends on the evolutionary forces under way at the moment of the emergence.
Considering an immunocompetent host organic system, if the new amino acids mutations leads to a very intense immune response to an important epitope, to immunological similarity with PhI that could activate immune memory, lower virulence or replication rate or a diminished affinity for cell membrane receptors, this is a deleterious mutant which will not stand in the population as it will be eliminated by the infected organic system according to the purifying selection, lowering amino acid polymorphism and leading to the predominance of synonymous nucleotide substitutions.
On the same way, as the affinity of RNA for the cellular retinoic-acid-inducible gene I (RIG-I) protein complex increases the expression of interferon in a sequencedependent way (Masatani et al. 2011) , nucleotide mutations that are synonymous in terms of amino acids but that alter RNA structure might alter the binding affinity to RIG-I: the lack of RIG-I RNA binding leads to a lower IFN response and thus contributes to the positive selection.
Concurrently, if the new PhI amino acids mutant is now low immunogenic, harbors low immunological similarity with the other representatives of PhI, has a higher affinity for cell receptors or higher virulence or replication rate, this mutant might evade the negative selection exerted by the host and its characters will be fixed in this new subpopulations in the positive selection mode.
57 Besides, if the mutant PhI is immunologically closely related to the dominant types in PhI, it sometimes might also be that this is advantageous for the mutant, contrarily to what was exposed before, if this mutant has antigens that will preferably activate the immune memory that was formed after classic PhI infection rather than elicit a new, specific response and this antigenic interference (Frank 2002) will camouflage it in the host.
If one of the two last pathogen-favorable paths take place, PhI now starts accumulating nucleotide and amino acids mutations if a cycle of positive selection derived from the aforementioned events establishes, setting up the neutral network for the probability of the occurrence of a definitive mutation that will lead to the change in the phenotype by epochal evolution (Cobey & Koelle 2008) , resulting in a escape mutant that now starts Phenotype II (PhII), for which a set of genomes that can be noted as GII 1,N and for which a fitness of w II is assigned.
If PhII now differs from PhI in antigenic terms, the host in which PhII has emerged or the new host individual to which it has spread to will not be able to set up an effective immune response to the new phenotype and PhII enters in an population expansion phase in a given individual host or host population, leading to a higher incidence of the disease associated to this pathogen and a higher number of infected (I) hosts, what might lead to the perpetuation of the disease and also epidemics.
Here, the host-genotype and parasite genotype evolution-optimized compatibility hypothesis (Lambrechts et al. 2006) can be accommodated as the biological basis for the increased proportion of infected individuals, as this would favor the virus replication cycle and the acquisition of this pathogen by the next susceptible host.
But, even during a period of epidemics, depending on the lethality and acuteness/ chronicity of the disease, population immunity starts increasing for the population of recovered (R) hosts or the number of host decreases due to the fatal cases as a factor of the disease lethality, decreasing I and leading to an increased host population with time.
Nonetheless, after a period, as a consequence of a higher number of non-immune hosts that were born after the epidemics, a higher number of susceptibles (S) is available, making an ideal host population environment for the continued expansion of PhII.
But a major vector directly derived from pathogen-host interaction virtual space that acts on the selection is the disease behavior that emerges from the infected host.
58 For instance, in the case of rabies, rabies virus leads to increased aggressive behavior and this enhances the virus transmission (Brandão 2009 ), making a positive disease behavior.
Oppositely, if a pathogen leads to fever and muscle pain as, for instance, in the case of influenza (Ebell & Afonso 2011) , the infected host will now tend not to move, what decreases the probability of encounters between infected and susceptible individuals, i.e., there's a negative disease behavior.
Extrapolating these two examples of disease behavior to the neutral network evolution, one can argue thus that if a mutant genotype leads to a negative disease behavior, I will decrease and, as genetic diversity is dependent on population number, the number of pathogen individuals in the neutral network will decrease, decreasing the amino acids diversity for the phenotype.
In the positive disease behavior path, I will increase instead, increasing the genetic diversity of the neutral network and the amino acids diversity of the phenotype, allowing the emergence of a new phenotype by epochal evolution.
The integration of all these events mentioned in this section are the basis of the emergence of escape mutants during epidemics, what is directly dependent of the duration of a disease and of an epidemics.
At this point, when PhII is the dominant phenotype involved in a given disease, the ecological advantage and the higher fitness (w II >w I ) it has when compared to PhI guides PhI to a lower replication rate due to the competition by both hosts and their receptors and PhI population decreases, leading its replacement rate, i.e., the rate of the emergence of new PhI individuals, to a critical level, as a result of an error rate above the error threshold (the maximum copying error rate for the maintenance of genetic information), bellow which PhI replication in the host individual or population is no longer enough to maintain neutral network I, following extinction by error catastrophe, when errors in the expression of the replicase protein complex lead to errors in replication accuracy and thus to an increased error rate in a recurrent chain reaction leading eventually to extinction (Domingo et al. 2002 , Biebricher & Eigen 2005 , Bull et al. 2005 . Now the epidemiological scenario is reset to the beginning and PhII is now placed at the start of the system and is subjected to all the series of events described.
59 A binomial qualitative equilibrium emerges from the host-pathogen relationship Any law on RNA virus disease evolution must always be derived taking the quasispecies concept into account. As a result of the mutation rates in RNA viruses, a given viral population can be categorized as a mathematical representation based on deleterious mutations resulting in a defined population (Belshaw et al. 2008) , in which a dominant RNA species occurs at higher frequency and low-frequency RNA types which are highly related to each other and to the dominant RNA species exist as the remaining possible combinations of nucleotide-states that are not yet diverse enough to allow for the definition of a new species and are thus called quasispecies.
Though a long discussion has been raised on the deference between the quasispecies model and the conventional population genetics, there's no conflict indeed if the quasispecies is taken as a molecular rather than a biological definition (Belshaw et al. 2008 ) and this all the propositions in this article assume this interpretation.
It can be proposed that the flow of events described in the previous section depends on three compartments: host (H), pathogen (P) and epidemiological (E) and can be qualitatively categorized as positive or negative, being the direction of the disease or epidemics ruled by the balance between binomial combinations of these that depends on the states (negative/cost or positive/benefit) of H, P and E characters..
As a consequence, disease behavior is the result of H and P states and if the result is negative, i.e., the host-to-parasite interference negatively influences the trend of the disease spreading (-H→P), it leads directly to an decreased I value as discussed, now providing an negative epidemiological-to-pathogen interaction (-E→P) as it's not favorable to the pathogen population expansion once transmission is lower.
An example of -H→P as a result of host differences comes from the transmission dynamics of rabies virus lineages between bats from two different lineages: the higher the phylogenetic distance between the transmitting and the acquiring bat, the lower the probability that a sustained new cycle of the disease emerges amongst the population of the last, although the individual bat does acquires rabies and dies from the infection (Streicker et al. 2010) At the point PhI reaches error threshold, one has now a pathogen phenotype negatively influencing another one, as the emerging PhII prevails ecologically, making (-PhII/PhI). This negative relationship amongst individuals in a quasispecies could also be due to the cross immunity amongst different representatives of a neutral network, e.g., PhI, which has already been proposed as the main cost of antigenic diversity as a trade for a higher duration of infection and higher transmission (Lange & Ferguson 2009) .
A collaborative network between pathogens might be conceived.
It has now to be suggested what happens if a high pathogenic and a low pathogenic form of a same phenotype of a pathogen co-exist in a host population, i.e., in cases of co-infection.
It's important to stress that if these two phenotypes of this pathogen belong to a same serotype, the neutralizing immune features will not play a different role in the selection of each of these, though antigen interference might still occur.
If the pathology in this case is dependent on the cell immune response or the cytokine response, i.e., there's an immunopathology involved as, for instance, in the case of influenza (Arias et al. 2009 ), a high pathogenic strain should be that which leads to an immune response so intense that the host is quickly lead to death.
But the death of a high number of hosts avoids the spreading of this high pathogenic strain as a lower number of hosts is available, reducing R 0 . This means that the best immune responders will die, leaving the bad responders alive and increasing S to the low pathogenic strain that would be negatively selected if it infected good responders (due to immunological clearance) and would not lead these to death due to its lower virulence.
At this point, one has an epidemiological situation in which immunoincompetent hosts have been selected, what is positive to the low pathogenic strain to gain access to these hosts and to spread with a higher R 0 in comparison to the case of the absence of a previous outbreak by the high pathogenic strain which exerted a purifying selection on good responders.
Another form of interaction that might be proposed is that phenotypes with high virulence in which virulence is an enhancer of transmissibility would help low virulent strains to be transmitted if these two phenotypes of a same pathogen species share a same transmission mode, because the high virulent form would increase symptoms and thus increase its shed from the host to another susceptible, enhancing also the transmission of the low virulent strain.
61 This last model might be an explanation for an example of highly complex diseases such as bovine viral diarrhea, caused by bovine viral diarrhea virus (BVDV) (Flaviviridae: Pestivirus).
BVDV occurs as two distinct biotypes: cytopathogenic BVDV (CP-BVDV) and non-cytopathogenic BVDV (NCP-BVDV). CP-BVDV causes diarrhea in cattle, leading to high viral titres being shed in the feces of affected animals, i.e., the higher the symptoms, the higher virus shed. On the other hand, if NCP-BVDV infects an animal which is immunocompetent against this virus, the virus will most probably be cleared and no infection will establish. An in deep review of BVDV is found in Peterhans and Schweizer (2010) .
But if NCP-BVDV infects a bovine fetus when its immune system is not fully developed, i.e., before the third month of development, the virus might be defined as self by the immune system and reaches a persistent infection.
Then, if this persistently infected animal is born and is next infected by an antigenically similar CP-BVDV strain, the virulence of this last strain will be expressed with no control from the immune system, as the host recognizes BVDV as a self antigen.
The symptoms will therefore be much more intense in this case and include not only diarrhea, but also mucosal lesions, a way out for the viruses. And the transmission of the NCP-BVDV, which would be theoretically low in the single-infection scenario, might be much increased by the symptoms caused by the CP-BVDV infection. This is thus a case of transmission-helper pathogen.
But if CP-BDVD, the more virulent phenotype, has a higher ability to replicate and increase its population, it would have a trend to keep the low-pathogenic type in replicative disadvantage due to both competition by receptors and host biochemical resources, keeping its own genotype at high frequencies.
In this model, quasispecies in a RNA virus might also be considered as a collaborative network if one takes into account not only that high-fitness sequences allow lower-fitness sequences to be kept in a population, but also that there's a negative feedback among high and low-fitness sequences, leading to the decrease in the highfitness and increase in the low-fitness one (Lauring & Andino, 2010) , resulting in a neutral network buffering system. But, contrary to the traditional point of view of the quasispecies structure which described a quasispecies as a physically existing set of RNA genomes, it can be proposed that each RNA in a quasispecies does not exist only as a molecule, but also as VIRUS REVIEWS AND RESEARCH 15, Nr. 2, 2010 62 a probability. A given RNA of the quasispecies is thus always present, be it physically as a molecule or virtually as a probability, which is modulated by the mutation rate and the replication efficiency of the virus and then each nucleotide in an RNA stores the probability of the emergence of a single-point mutation.
The advantage of the neutral network buffering system is that a larger repertoire of genomes is present for the selection picking from memory genomes (Domingo et al. 2002) , allowing an infection wave to move forward despite host negative pressures, i.e., the quasispecies with the flattest sequence space in a fitness scale under high mutation rates would be favored not only in terms of immune escape, but also higher virulence (Lauring & Andino, 2010) , which might be thus speculated as a result of the equilibrium between virulence and transmission as a consequence of the minimization of virulence as proposed by Lambrechts et al. (2006) .
CONCLUSION
Thus a general model for the prediction of the clinical course of a RNA-virus caused epidemic should accommodate the probability of amino acids mutations of the pathogen, the probability of purifying selection by immune response and the probability of transmission of the pathogen. On their turn, each of these probabilities is modulated by the pathogens characteristics, the species and immune status of the individual host and the population densities and herd immunity.
Still a large number of restrictions to the models proposed herein remain to be explored, such as more complex virus communities as retroviruses, the interspecies transmission of viral agents, the influence of host age and the influence of the disease chronicity on the virus population genetics and transmission, which will be then issue of future works.
Empirical data from in vitro and in vivo evolution of RNA-viruses coupled with transmission experiments and a mathematical approach for the models proposed herein could bring some benefit for the improvement of the hypothesis depicted in this article.
